Biography

Dr. Andrey Golubov earned his Biology Diploma in 2001 and completed a PhD in Comparative Genomics of Yersinia at LMU Munich in 2005. From 2005 to 2022, he held various research roles in the USA, Canada, and Germany, specializing in the field of Molecular Biology and Genetic Engineering. Since 2022, he has led R&D at IMLred/SNRL Gauting, managing international TB diagnostics projects and overseeing study design, data analysis, and project coordination.

Expertise

TB Diagnostics
Public Health

Key Impacts

One-day TB diagnosis and resistance mapping with BD MAX MDR-TB and ONT AmPORE assays

Integrating BD Max™ with ONT-based tNGS offers a rapid, accurate, and comprehensive diagnostic tool for MDR/XDR-TB, with potential for same-day results from a single sputum sample.

Source: Conference 2024